Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
作者信息
Lopes Renato D, de Barros E Silva Pedro Gabriel Melo, Furtado Remo H M, Alexander John H, Berwanger Otavio
机构信息
Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27701, USA.
Brazilian Clinical Research Institute, Sao Paulo, Brazil.
出版信息
Lancet. 2021 Oct 9;398(10308):1304. doi: 10.1016/S0140-6736(21)01909-7.
Abstract
摘要
相似文献
1
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.用于指导COVID-19抗凝治疗的年龄调整D-二聚体临界值——作者回复
Lancet. 2021 Oct 9;398(10308):1304. doi: 10.1016/S0140-6736(21)01909-7.
2
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.用于指导COVID-19抗凝治疗的年龄调整D-二聚体临界值。
Lancet. 2021 Oct 9;398(10308):1303-1304. doi: 10.1016/S0140-6736(21)01859-6.
3
D-dimer levels predict COVID-19 severity and mortality. Authors' reply.D-二聚体水平可预测新冠病毒疾病的严重程度和死亡率。作者回复。
Kardiol Pol. 2021 Feb 25;79(2):218-219. doi: 10.33963/KP.15831.
4
Reply to the authors of "Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients".对《用于排除COVID-19患者静脉血栓栓塞的年龄校正D-二聚体临界值》一文作者的回复
Anaesth Crit Care Pain Med. 2021 Oct;40(5):100940. doi: 10.1016/j.accpm.2021.100940. Epub 2021 Aug 13.
5
Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.新冠病毒肺炎中纤维蛋白原和D-二聚体的变化及抗凝建议：当前文献综述
Rev Assoc Med Bras (1992). 2020 Jun;66(6):842-848. doi: 10.1590/1806-9282.66.6.842. Epub 2020 Jul 20.
6
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.COVID-19 中的抗凝治疗：依诺肝素、肝素和阿哌沙班对死亡率的影响。
Thromb Haemost. 2020 Dec;120(12):1691-1699. doi: 10.1055/s-0040-1720978. Epub 2020 Nov 13.
7
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.血栓弹力描记术凝块强度谱和全身抗凝对 COVID-19 急性呼吸窘迫综合征的影响：一项前瞻性、观察性研究。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12466-12479. doi: 10.26355/eurrev_202012_24043.
8
Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising Youden's index.新型冠状病毒肺炎相关肺血栓栓塞症：D-二聚体截断值选择不应基于最大化约登指数。
Eur Respir J. 2021 Feb 4;57(2). doi: 10.1183/13993003.04279-2020. Print 2021 Feb.
9
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病：治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验)：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
10
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.新冠病毒病（COVID-19）合并D-二聚体浓度升高住院患者的治疗性与预防性抗凝治疗（ACTION）：一项开放标签、多中心、随机对照试验
Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.
本文引用的文献
1
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.新冠肺炎危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
2
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.COVID-19 非危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
3
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.新冠病毒病（COVID-19）合并D-二聚体浓度升高住院患者的治疗性与预防性抗凝治疗（ACTION）：一项开放标签、多中心、随机对照试验
Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.
4
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.美国血液学会2020年静脉血栓栓塞管理指南：深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
5
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
Zotero 插件